155 related articles for article (PubMed ID: 14631218)
1. A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens.
Buskens CJ; Marsman WA; Wesseling JG; Offerhaus GJ; Yamamoto M; Curiel DT; Bosma PJ; van Lanschot JJ
Ann Surg; 2003 Dec; 238(6):815-24; discussion 825-6. PubMed ID: 14631218
[TBL] [Abstract][Full Text] [Related]
2. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
Heideman DA; Snijders PJ; Craanen ME; Bloemena E; Meijer CJ; Meuwissen SG; van Beusechem VW; Pinedo HM; Curiel DT; Haisma HJ; Gerritsen WR
Cancer Gene Ther; 2001 May; 8(5):342-51. PubMed ID: 11477454
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.
Marsman WA; Buskens CJ; Wesseling JG; Offerhaus GJ; Bergman JJ; Tytgat GN; van Lanschot JJ; Bosma PJ
Cancer Gene Ther; 2004 Apr; 11(4):289-96. PubMed ID: 14765131
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer mediated by native versus fibroblast growth factor-retargeted adenoviral vectors into lung cancer cells.
Qin M; Escuadro B; Sharma S; Batra RK
Am J Respir Cell Mol Biol; 2005 Mar; 32(3):211-7. PubMed ID: 15626775
[TBL] [Abstract][Full Text] [Related]
7. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
8. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
[TBL] [Abstract][Full Text] [Related]
9. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.
Blackwell JL; Miller CR; Douglas JT; Li H; Reynolds PN; Carroll WR; Peters GE; Strong TV; Curiel DT
Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):856-63. PubMed ID: 10448731
[TBL] [Abstract][Full Text] [Related]
10. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
12. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
13. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
[TBL] [Abstract][Full Text] [Related]
14. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
[TBL] [Abstract][Full Text] [Related]
15. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches.
Vanderkwaak TJ; Wang M; Gómez-Navarro J; Rancourt C; Dmitriev I; Krasnykh V; Barnes M; Siegal GP; Alvarez R; Curiel DT
Gynecol Oncol; 1999 Aug; 74(2):227-34. PubMed ID: 10419736
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.
Kraaij R; van Rijswijk AL; Oomen MH; Haisma HJ; Bangma CH
Prostate; 2005 Feb; 62(3):253-9. PubMed ID: 15389777
[TBL] [Abstract][Full Text] [Related]
18. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
19. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide.
Koizumi N; Mizuguchi H; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Biochim Biophys Acta; 2001 Nov; 1568(1):13-20. PubMed ID: 11731080
[TBL] [Abstract][Full Text] [Related]
20. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
